Needle Free Drug Delivery Devices Market to Rake in Nearly US $13 Bn in Terms of Revenue by the End of 2023
The nature of the business landscape is highly consolidated with the alliances between the companies operating in the needle-free delivery devices market increasing, states Transparency Market Research (TMR) in a research report. The leading three companies, namely, Antares Pharma Inc., 3M, and Zogenix collectively held a share of over 60% in the global market for needle free drug delivery in 2014. Apart from partnerships, acquisitions, and mergers, the core vendors are now focusing on the introduction of advanced devices on...
View full press release